TBG Diagnostics has announced that it will acquire a 51% stake in RBC Biosciences Corp. for a purchase consideration of $4m.

The acquisition is expected to be completed by August 2016 and will provide TBG Diagnostics with sales and distribution opportunities in the global diagnostics market.

Charles River Laboratories International has acquired Blue Stream Laboratories to develop its biological testing solutions business to compete in the growing market segment.

According to the agreement, Blue Stream Labs will be combined with Charles River Labs’ discovery, safety assessment and biologics capabilities to develop biologics and biosimilars from characterisation through clinical testing and commercialisation.

Pharmaceutical Technology Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Pharmaceutical Technology Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now